Bardeesy N - Search Results

1

Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer.

Alagesan B, Contino G, Guimaraes AR, Corcoran RB, Deshpande V, Wojtkiewicz GR, Hezel AF, Wong KK, Loda M, Weissleder R, Benes CH, Engelman J, Bardeesy N. Alagesan B, et al. Among authors: bardeesy n. Clin Cancer Res. 2015 Jan 15;21(2):396-404. doi: 10.1158/1078-0432.CCR-14-1591. Epub 2014 Oct 27. Clin Cancer Res. 2015. PMID: 25348516 Free PMC article.

2

Animal models of melanoma: recent advances and future prospects.

Bardeesy N, Wong KK, DePinho RA, Chin L. Bardeesy N, et al. Adv Cancer Res. 2000;79:123-56. doi: 10.1016/s0065-230x(00)79004-x. Adv Cancer Res. 2000. PMID: 10818679 Review. No abstract available.

3

Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Bardeesy N, Bastian BC, Hezel A, Pinkel D, DePinho RA, Chin L. Bardeesy N, et al. Mol Cell Biol. 2001 Mar;21(6):2144-53. doi: 10.1128/MCB.21.6.2144-2153.2001. Mol Cell Biol. 2001. PMID: 11238948 Free PMC article.

4

The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.

Bardeesy N, Sharpless NE, DePinho RA, Merlino G. Bardeesy N, et al. Semin Cancer Biol. 2001 Jun;11(3):201-18. doi: 10.1006/scbi.2000.0371. Semin Cancer Biol. 2001. PMID: 11407945 Review.

5

Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.

Bardeesy N, Morgan J, Sinha M, Signoretti S, Srivastava S, Loda M, Merlino G, DePinho RA. Bardeesy N, et al. Mol Cell Biol. 2002 Jan;22(2):635-43. doi: 10.1128/MCB.22.2.635-643.2002. Mol Cell Biol. 2002. PMID: 11756558 Free PMC article.

6

Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.

Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, Sharpless NE, Loda M, Carrasco DR, DePinho RA. Bardeesy N, et al. Nature. 2002 Sep 12;419(6903):162-7. doi: 10.1038/nature01045. Nature. 2002. PMID: 12226664 Free article.

7

Pancreatic cancer biology and genetics.

Bardeesy N, DePinho RA. Bardeesy N, et al. Nat Rev Cancer. 2002 Dec;2(12):897-909. doi: 10.1038/nrc949. Nat Rev Cancer. 2002. PMID: 12459728 Review.

8

Telomere induced senescence: end game signaling.

Hezel AF, Bardeesy N, Maser RS. Hezel AF, et al. Among authors: bardeesy n. Curr Mol Med. 2005 Mar;5(2):145-52. doi: 10.2174/1566524053586563. Curr Mol Med. 2005. PMID: 15974867 Review.

9

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Bardeesy N, Aguirre AJ, Chu GC, Cheng KH, Lopez LV, Hezel AF, Feng B, Brennan C, Weissleder R, Mahmood U, Hanahan D, Redston MS, Chin L, Depinho RA. Bardeesy N, et al. Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5947-52. doi: 10.1073/pnas.0601273103. Epub 2006 Apr 3. Proc Natl Acad Sci U S A. 2006. PMID: 16585505 Free PMC article.

10

Genetics and biology of pancreatic ductal adenocarcinoma.

Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Hezel AF, et al. Among authors: bardeesy n. Genes Dev. 2006 May 15;20(10):1218-49. doi: 10.1101/gad.1415606. Genes Dev. 2006. PMID: 16702400 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page